Paradigm Biocapital Advisors LP Kymera Therapeutics, Inc. Transaction History

Paradigm Biocapital Advisors LP

  • $2.67 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$14.13 - $42.55 $3.21 Million - $9.66 Million
-227,034 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$35.3 - $64.68 $3.57 Million - $6.54 Million
101,176 Added 80.39%
227,034 $9.61 Million
Q4 2021

Feb 14, 2022
BUY
$49.91 - $65.56 $6.28 Million - $8.25 Million
125,858 New
125,858 $7.99 Million

Others Institutions Holding KYMR

# of Institutions
164
Shares Held
63.1M
Call Options Held
39.7K
Put Options Held
9.7K
View Full List

About Kymera Therapeutics, Inc.

KYMR Quotes by TradingView
  • Ticker KYMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,705,800
  • Market Cap $1.63B
  • Description
  • Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...
More about KYMR
Track This Portfolio

Track Paradigm Biocapital Advisors LP Portfolio

Follow Paradigm Biocapital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Biocapital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Biocapital Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email